1.40
price down icon1.41%   -0.02
after-market Dopo l'orario di chiusura: 1.38 -0.02 -1.43%
loading

Telomir Pharmaceuticals Inc Borsa (TELO) Ultime notizie

pulisher
Dec 15, 2025

TELO Stock Jumps Pre-market After Early Study Results Show Leukemia Cell Death - MSN

Dec 15, 2025
pulisher
Dec 09, 2025

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells - USA Today

Dec 09, 2025
pulisher
Dec 06, 2025

Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells - Daily Commercial

Dec 06, 2025
pulisher
Dec 05, 2025

Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 05, 2025
pulisher
Dec 05, 2025

Why Telomir Pharmaceuticals Inc. stock attracts high net worth investorsTrade Signal Summary & Free Community Supported Trade Ideas - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Telomir Pharmaceuticals (NASDAQ:TELO) Shares Up 2.3% – Still a Buy? - Defense World

Dec 04, 2025
pulisher
Nov 29, 2025

Is Telomir Pharmaceuticals Inc. stock positioned for digital transformationJuly 2025 Chart Watch & Real-Time Volume Triggers - moha.gov.vn

Nov 29, 2025
pulisher
Nov 28, 2025

Telomir Pharmaceuticals announces new preclinical data on Telomir-1 - MSN

Nov 28, 2025
pulisher
Nov 27, 2025

Telomir and Mira Pharmaceuticals advance through key development milestones with Recipharm support - marketscreener.com

Nov 27, 2025
pulisher
Nov 26, 2025

Telomir Pharmaceuticals Unveils Promising Preclinical Cancer Data - MSN

Nov 26, 2025
pulisher
Nov 25, 2025

Telomir reports PSA reduction in prostate cancer cells with lead drug - Investing.com Nigeria

Nov 25, 2025
pulisher
Nov 25, 2025

Telomir reports PSA reduction in prostate cancer cells with lead drug By Investing.com - Investing.com South Africa

Nov 25, 2025
pulisher
Nov 24, 2025

Telomir Pharmaceuticals Reports Promising Preclinical Data - TipRanks

Nov 24, 2025
pulisher
Nov 24, 2025

[8-K] Telomir Pharmaceuticals, Inc. Reports Material Event | TELO SEC FilingForm 8-K - Stock Titan

Nov 24, 2025
pulisher
Nov 23, 2025

Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells - Bluffton Today

Nov 23, 2025
pulisher
Nov 21, 2025

Will Telomir Pharmaceuticals Bounce Back? - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

Telomir Pharmaceuticals (TELO) Unveils Leukemia Breakthrough and Board Change – Full Investor Update for November 21, 2025 - ts2.tech

Nov 21, 2025
pulisher
Nov 21, 2025

Telomir stock surges after leukemia cell-killing data By Investing.com - Investing.com Nigeria

Nov 21, 2025
pulisher
Nov 21, 2025

Telomir stock surges after leukemia cell-killing data - Investing.com UK

Nov 21, 2025
pulisher
Nov 21, 2025

Telomir Pharma (NASDAQ: TELO) Telomir-1 Shows Preclinical HL60 Leukemia Activity - Stock Titan

Nov 21, 2025
pulisher
Nov 20, 2025

Telomir Pharmaceuticals director Craig Eagle resigns from board By Investing.com - Investing.com Australia

Nov 20, 2025
pulisher
Nov 20, 2025

Telomir Pharmaceuticals director Craig Eagle resigns from board - Investing.com

Nov 20, 2025
pulisher
Nov 20, 2025

Telomir Pharmaceuticals Inc. Announces Resignation of Craig Eagle as Director, Effective on November 14, 2025 - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

Telomir Pharmaceuticals’ Telomir-1 Shows Leukemia Efficacy - TipRanks

Nov 20, 2025
pulisher
Nov 20, 2025

Telomir Pharmaceuticals, Inc. Announces Telomir-1 Kills Aggressive Human Leukemia Cells - marketscreener.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Telomir Pharmaceuticals Inc. stock performs after earnings2025 Market Overview & Precise Buy Zone Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Does Telomir Pharmaceuticals Inc. stock trade at a discount to peersQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will Telomir Pharmaceuticals Inc. bounce back from current supportMarket Activity Recap & Precise Buy Zone Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Has Telomir Pharmaceuticals Inc. found a price floorJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Telomir Pharmaceuticals Completes $2.9 Million Stock Sale - MSN

Nov 19, 2025
pulisher
Nov 19, 2025

Analyzing Telomir Pharmaceuticals Inc. with risk reward ratio charts2025 AllTime Highs & Daily Volume Surge Trade Alerts - newser.com

Nov 19, 2025
$38.38
price down icon 0.39%
$97.03
price down icon 1.63%
$31.35
price down icon 0.70%
$92.23
price down icon 1.68%
biotechnology ONC
$304.31
price down icon 2.05%
$200.67
price up icon 1.90%
Capitalizzazione:     |  Volume (24 ore):